Breaking News
July 23, 2018 - No Outcome Differences Based on Anesthesia Team Make-Up
July 23, 2018 - Getting to the heart of congenital cardiac defects
July 23, 2018 - Healthy behaviors are not effective in preventing gestational diabetes in obese women
July 23, 2018 - Top of Teachers’ To-Do List: Focus on the Positives
July 23, 2018 - LDL quality is a novel, modifiable cardiovascular risk marker
July 22, 2018 - Researchers identify enzyme as potential new drug target for blood disorders
July 22, 2018 - Research shows that neurons can encode more than one signal at a time
July 22, 2018 - Exposure to secondhand smoke increases the risk of stillbirth
July 22, 2018 - Skin conditions by the numbers
July 22, 2018 - Brain tumour chemotherapy now available to even more NHS patients
July 22, 2018 - Researchers find mugwort pollen as major source of airborne endotoxins
July 22, 2018 - Occupational safety and health at workplace
July 22, 2018 - Pfizer And Lilly Announce Positive Top-Line Results From Phase 3 Trial Of Tanezumab For The Treatment Of Osteoarthritis (OA) Pain
July 22, 2018 - Early supper associated with lower risk of breast and prostate cancer
July 22, 2018 - Survey results identify major inequalities in acute stroke treatment across Europe
July 22, 2018 - Researchers discover promising treatment for genetic form of autism spectrum disorder
July 22, 2018 - Prenatal Depression More Common in Young Moms Today
July 22, 2018 - What helps adults with autism get and keep a job?
July 22, 2018 - Pediatric NEXUS Head CT DI guides selective imaging decisions in blunt trauma patients
July 22, 2018 - Novel tool predicts genes that cause disease due to production of truncated proteins
July 22, 2018 - AHA: Vaping Tied to Blood Clots — in Mice
July 22, 2018 - Study finds therapy dogs effective in reducing symptoms of ADHD
July 22, 2018 - Scientists find reason why malarial parasites are faster than immune cells
July 22, 2018 - Researchers gain more insight into how FUS protein causes ALS and FTLD
July 22, 2018 - Frequency of joint replacements halved in rheumatoid arthritis patients between 1997-2010
July 22, 2018 - QUT researcher highlights growing impact of non-prescription antibiotics supply in pharmacies
July 22, 2018 - UK health communication researcher seeks solutions for disposing leftover medicine
July 22, 2018 - Pfizer Initiates Pivotal Phase 3 Program for Investigational Hemophilia B Gene Therapy Fidanacogene Elaparvovec
July 22, 2018 - Mutation discovered to protect against Alzheimer’s disease in mice
July 22, 2018 - Researchers reveal how patients in urban areas develop multiple, long-term conditions
July 22, 2018 - Replacing conventional cancer treatment with complementary therapy linked to increased risk of death
July 22, 2018 - Study uncovers molecular key for delaying progression of multiple sclerosis
July 22, 2018 - Availability of athletic trainer in high school reduces injury rates in girls’ sports, shows study
July 22, 2018 - FDA Approves Krintafel (tafenoquine) for the Radical Cure of Plasmodium vivax Malaria
July 22, 2018 - Novel nuclear medicine probe will help assess new drugs for neurodegenerative diseases
July 22, 2018 - Physical activity even during exposure to air pollution can reduce risk of heart attack
July 22, 2018 - Scientists discover protein regulator of myelin production
July 22, 2018 - Sleep disturbances associated with higher dementia risk
July 22, 2018 - Scientists move one step further in developing eye drops to treat age-related macular degeneration
July 22, 2018 - Five-Year Stroke Rates Lower After PCI Versus CABG
July 21, 2018 - Alopecia areata – Genetics Home Reference
July 21, 2018 - Study identifies overdose risk factors in youth with substance use disorders
July 21, 2018 - Drug in clinical trials for Parkinson’s disease offers hope for treating heart failure
July 21, 2018 - Coupling free malaria tests with diagnosis-dependent vouchers can improve rational use of ACTs
July 21, 2018 - Sweetness depends on molecular interactions between specific sugars and water in saliva
July 21, 2018 - Muscle fitness is strongly associated with improved rate of ageing in the brain
July 21, 2018 - Resetting E-Prescriptions for Opioids Helps Curb Use: Study
July 21, 2018 - Overuse of antibiotics not what the doctor ordered
July 21, 2018 - Bundled-payment system did not lower costs for serious medical conditions, shows study
July 21, 2018 - Therapy dogs found to be effective in reducing ADHD symptoms in children
July 21, 2018 - Could rotating multiple therapists better treat PTSD patients?
July 21, 2018 - Binge drinking impairs working memory in adolescent brain
July 21, 2018 - Dying at home could be beneficial for terminally ill cancer patients and their relatives
July 21, 2018 - Researchers identify subtypes of retinal ganglion cells using single-cell RNA sequencing
July 21, 2018 - Study uncovers opportunities to reduce death by suicide among cancer patients
July 21, 2018 - Genetic sequencing reveals new clues to aggressiveness of prostate cancer
July 21, 2018 - BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia
July 21, 2018 - First major study comparing robotic to open surgery published in The Lancet
July 21, 2018 - ADHD medications may fail to improve cognition in healthy college students, study shows
July 21, 2018 - Intervention program that includes a personalized app could benefit teens with suicidal thoughts
July 21, 2018 - Researchers identify new compound that protects against neurodegeneration
July 21, 2018 - Gene therapy may hold potential to treat people with spinal cord injuries
July 21, 2018 - FDA Approves Nivestym (filgrastim-aafi), a Biosimilar to Neupogen
July 21, 2018 - Surgeons have substantial impact on genetic testing in breast cancer patients who need it
July 21, 2018 - Species diversity can have positive and negative impacts on disease transmission
July 21, 2018 - Genome research suggests presence of enteric fever in medieval Europe
July 21, 2018 - Risk of Sensory Deficits Drops With Rising Gestational Age
July 21, 2018 - Mum’s sleep matters—the effect of sleep on an unborn baby
July 21, 2018 - UC San Diego researchers awarded two grants for investigating stem cell-based therapies
July 21, 2018 - Cellular ‘garbage disposal’ may actually work on some of the proteins to neuronal development
July 21, 2018 - More Pregnant Women Having Heart Attacks
July 21, 2018 - Acne Breakouts | NIH News in Health
July 21, 2018 - Change health messaging to focus on potential impact to help stop the next pandemic
July 21, 2018 - Frailty associated with poor survival rates in young heart patients
July 21, 2018 - New discovery could save millions of lives from fatal fungal infections
July 21, 2018 - OBD presents latest data on the use of EpiSwitch™ in predicting patient response to immunotherapy and identifying lymphoma subtypes
July 21, 2018 - Childhood adversity increases susceptibility to addiction via immune response
July 21, 2018 - Scientists identify potential target for the treatment of binge eating
July 21, 2018 - Whole-brain LIPUS therapy improves cognitive dysfunction in mice simulating dementia, Alzheimer’s
July 21, 2018 - Digital media use raising risk of ADHD symptoms among the young
Blood take a look at might expect medicine results for sufferers with localized NSCLC

Blood take a look at might expect medicine results for sufferers with localized NSCLC

image_pdfDownload PDFimage_print

A brand new learn about demonstrates blood take a look at to come across most cancers might expect medicine results for sufferers with localized non-small cellular lung most cancers (NSCLC) and come up with the money for physicians further lead time to personalize medicine for recurrent illness. Sufferers within the learn about with detectable ranges of circulating tumor DNA (ctDNA) in a while after medicine all had recurrences inside of two years, whilst all however one of the vital sufferers with out detectable ctDNA in a while after medicine remained disease-free and survived long-term. Typical imaging, conversely, was once no longer prognostic for recurrence or survival. Findings will probably be offered as of late on the 59th Annual Assembly of the American Society for Radiation Oncology (ASTRO).

The competitive nature of lung most cancers could make long-term control particularly difficult. As a result of NSCLC has a tendency to development, even following medicine, common tracking for recurrence is essential. The CT scans in most cases used for tracking, then again, are steadily not able to come across microscopic tumor deposits or to tell apart standard tissue adjustments led to via medicine from adjustments led to via recurrent illness.

“Blood exams that may come across minute lines of most cancers that stay after medicine may just make stronger recurrence tracking and probably be offering physicians months of extra lead time to tailor therapies and make stronger our sufferers’ results and high quality of lifestyles,” stated Aadel Chaudhuri, MD, PhD, lead writer of the learn about and a major resident in radiation oncology at Stanford College in Palo Alto, California.

“Our findings recommend that ctDNA research, in contrast to CT scans, can determine in a while after medicine of completion if a affected person with localized lung most cancers has most probably been cured via radiation or surgical operation or if she or he nonetheless has most cancers cells provide of their frame. Whilst we anticipated that ctDNA detection of molecular residual illness would expect deficient scientific results, we had been shocked via how strongly predictive the take a look at was once for recurrence and survival.”

Presence of ctDNA was once measured as a marker of molecular residual illness (MRD) in sufferers with degree I-III NSCLC instantly earlier than medicine and in a while after medicine was once finished. ctDNA ranges additionally had been measured mid-treatment (reasonable = Three weeks, vary = 1.Four-Three.7 weeks) for part of the sufferers receiving chemoradiation (n = 13 of 27 sufferers). Most cancers Customized Profiling via Deep Sequencing (CAPP-Seq) was once used to evaluate whether or not ctDNA was once provide. Surveillance scans the use of CT imaging had been evaluated the use of the Reaction Analysis Standards In Forged Tumors (RECIST).

The median affected person age was once 67 years (vary 47-91 years), and maximum sufferers (67%) had been male. All 41 sufferers had been handled with healing intent, together with with chemoradiation remedy (66%), radiation remedy on my own (27%) and surgical operation on my own (7%). Median follow-up for the learn about was once 35 months (vary 7-56 months).

Researchers detected ctDNA pretreatment in 38 of the 41 sufferers (93%). Thirty-four of those 38 sufferers had blood drawn inside of 4 months of medicine of completion (the prespecified MRD landmark) and had been eligible for next research.

A few of the 34 sufferers with ctDNA MRD pretreatment, greater than part (56%, n = 19) had detectable residual illness after medicine. All of those sufferers therefore evolved recurrent lung most cancers, in comparison with most effective one of the vital 15 sufferers with out detectable ctDNA MRD.

Sufferers with detectable ctDNA MRD after medicine had worse freedom from development and survival than sufferers with out detectable ctDNA MRD (freedom from development Danger Ratio (HR) =, p < zero.0001; disease-specific survival HR = 27.7, p < zero.0001). CT imaging on the identical time was once no longer prognostic for survival. ctDNA ranges earlier than medicine additionally weren't related to survival results.

In 8 of the 13 sufferers assessed mid-treatment, ctDNA accounted for zero.1 p.c or extra of all cell-free DNA. For those sufferers, mid-treatment ctDNA ranges predicted eventual illness development (HR = 2.7, p = zero.006). Sixty p.c of the sufferers with not up to zero.1 p.c ctDNA mid-treatment had been progression-free at two years following medicine, in comparison to not one of the sufferers with zero.1 p.c or upper ranges of ctDNA (HR = Four.Four, p = zero.037).

“Someday, clinicians could possibly use ctDNA research to spot sufferers who may just get pleasure from further medicine after first-line remedy,” stated Maximilian Diehn, MD, PhD, senior writer of the learn about and an assistant professor of radiation oncology at Stanford.

“In a similar learn about additionally offered at this yr’s ASTRO Annual Assembly, we discovered that ctDNA research detected illness recurrence a mean five.five months previous than standard-of-care CT imaging for localized lung most cancers and helped with interpretation of equivocal follow-up imaging. This implies that ctDNA research may just open a window to regard sufferers with residual most cancers early, whilst illness burden is minimum.”​

Tagged with:

About author

Related Articles